ACET FY 2024 Earnings — Adicet Bio, Inc. Revenue & Financial Results | Market Cap Arena

ACETAdicet Bio, Inc.

$76M

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$128M

Net Income

-$117M

EPS (Diluted)

$-21.28

Cash Flow

Operating Cash Flow

-$92M

Free Cash Flow

-$93M

Stock-Based Comp.

$22M

Balance Sheet

Total Assets

$220M

Total Liabilities

$34M

Stockholders' Equity

$187M

Cash & Equivalents

$56M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$128M	-$152M	+16.1%
Net Income	-$117M	-$143M	+17.9%